There were 415 million persons living with diabetes worldwide, in 2015. By 2040, estimates suggest that this number will increase to 642 million. Diabetes may be Type-1, Type-1.5, Type-2 or Type Gestational.
Insulin is the only treatment for Type-1, the treatment of choice for Type-1.5 and Gestational diabetes, while a large number of person with Type-2 also have to rely on injecting insulin multiple times daily, either due to complications or non-effectiveness of oral medicines.
10% of the 422 Million people with diabetes rely on insulin, just like you rely on oxygen. Their pancreas does not produce insulin. They will die without external insulin.
Insulin is a life-saving medication; it should not be a privilege for a few.
Meethi Zindagi's 'Promise of Insulin' programme seeks to provide insulin to under privileged students with type 1 diabetes.
We aim to expand the Promise of Insulin Project to support approximately 2,500 children in 7-8 cities all over Pakistan in the next 4-5 years.
Meethi Zindagi has reached an understanding with 60+ schools for providing support to under-privileged students. Support package includes insulin, diabetes management accessories, medical consultation, diabetes management education, regular tests and of course peer support! Help children who endure hundreds of thousands of needles, countless finger pricks, numerous trips to the hospital and still lose the fight because of inaccessibility of Insulin. Create a brighter future by donating today.
Insulin cost per child
Non-Affording Students With Type 1 Diabetes To Get Free Treatment
Under the programme, schools will work closely with Meethi Zindagi to achieve two aims:
Diabetes type 1 is a physically and emotionally challenging condition. At a young age, when children, adolescents and young adults are already challenged with issues of coping up with growth, independence, learning, financial productivity and family, type1 diabetes presents an added complication.
Peer support presents an escape from the diabetes struggles. A child or young person with diabetes wants to feel like any other person.
People with diabetes understand each other and present friendship opportunities, which are often denied to them either because of
family’s protectiveness, judgmental attitudes of society and somber experiences with health care setups. People with diabetes want to
talk their hearts out and have fun.
Many people with type 1 diabetes have a wealth of experience, which is a valuable resource that can be tapped into. With a little guidance and training, peer supporters make friends with people with diabetes, and help them talk about their issues in groups or individually.
Meethi Zindagi’s DTreats are designed to provide group based peer support on regular intervals, in a non-judgmental environment. At a DTreat, it’s a fun gathering, where everyone attending is a friend. All the participants are provided psycho-social support and education in an unconventional fun way.
The presence of a fully trained peer educator is ensured to provide a safe learning environment at the same time. However, the participating educators and other health care professionals also have diabetes themselves. This ensures a true “peer-support” experience.
Diabetes Retreat Camps are a fun way of educating people with diabetes about self-management and giving them a sense of togetherness.
Diabetes education for families is on our list too!. We believe that a DTreat is a life changing experience for people with diabetes and their families!
There were 415 million persons living with diabetes worldwide, in 2015. By 2040, estimates suggest that this number will increase to 642 million. Diabetes may be type-1, type-1.5, type-2 or Type Gestational. Insulin is the only treatment for type-1, the treatment of choice for type-1.5 and Gestational diabetes, while a large number of person with type-2 also have to rely on injecting insulin multiple times daily, either due to complications or non-effectiveness of oral medicines.
Estimates for number of person using insulin worldwide are not available. Only three sources have provided data in the last 10 years for insulin requirement, pertaining only to developed countries. However, there is no exact data available. An estimate made by the International Diabetes Federation (IDF), on the number of person requiring insulin worldwide, in 2006, puts the figure between 17.9 million to 35.3 million. The data estimates are interpolated from. However, it has been noted in that the insulin usage has tripled in the UK alone in the period 1990-2010.
Insulin delivery to human body can be done through injections only, manually or automated. Although there is no overall consensus, it is widely accepted that those with frequent, severe hypoglycemia and/or hypoglycemia unawareness may derive particular benefit from using an automated injection system also called insulin pump.
Insulin Pump Therapy, also known as CSII (Continuous Subcutaneous Insulin Infusion) is a small computerized device that delivers insulin continuously to the user through a catheter placed under the skin. CSII follows the natural pancreatic insulin release through pre-programmed rates as well as user modifiable insulin delivery rates.
Insulin pump therapy is more expensive than Multiple Daily Injections (MDI). However, many health care and insurance systems, especially in the US and EU, are increasingly considering the Insulin Pump Therapy to be a lifestyle choice and are adapting policies accordingly. Insulin pumps present more flexibility in lifestyle, through granularity in insulin dosing and blood glucose level monitoring.
Insulin pump design varies across the pump manufacturing companies, each with its own set of advantages and disadvantages. However, no pump design simultaneously provides ease of use, reliability, simple and discrete operation, and efficient blood glucose management. The cost of buying and using a pump is prohibitively high, rendering its use a dream for most of those who need to pay out of pocket for medical care.
The proposed project aims to design, simulate and make prototypes for the insulin pump (named Lublin) and its user interface. The proposed pump design provides the following key features:
The proposed project aims to design, simulate and develop prototypes for the insulin pump and its user interface.
We believe that creating inspiration is the most important thing that people with diabetes do. People with diabetes, who want to become the face and voice of the diabetes community, are provided diabetes peer leadership trainings.
Our peer led communities are active on social media as well.
Hamari Meethi Zindagi is printed and electronic magazine and literature platform. It covers life stories of People with diabetes, motivational topics, new researches, FAQs, recipes and other diabetes related topics.
Hamari Meethi Zindagi is printed and electronic magazine and literature platform.
Meethi Zindagi is an association of people dealing with diabetes and was founded in March 2012. Meethi Zindagi was founded by a person living with diabetes, who envisioned improving lives of people with diabetes in Pakistan through a Patient-Centered approach.
Associations of people dealing with a certain health condition are instrumental in bringing about changes to the health care systems, by being a unification platform and voice for the people who are affected by a health condition, or are providing care to those affected by it. As the name suggests, Meethi Zindagi aims to target environmental, educational, political, financial, health, technological and psycho-social factors for improving the lives of people living with diabetes and its co-morbidities, thereby making their lives sweet.
Faysal Bank Limited, Haider Road, Rawalpindi, Pakistan